Acta Otorhinolaryngologica Italica · 2018 · 13 citations · 9 references
PharmacyOtolaryngologyPharmacotherapyInflammationMucosal Drug DeliveryRhinologyChronic RhinosinusitisMucosal InflammationMucosal TolerabilityNasal Drug DeliveryNasal FormulationsAnti-inflammatory ActivityAnti-inflammatory ResponseAnti-inflammatory TherapeuticsControl Group DesignMatched Control GroupNasal InflammationParanasal Sinus PathologyPharmacological Therapy
SUMMARY: The aim of this research is to investigate penetration of Bromelain into sinonasal mucosa in patients with chronic rhinosinusitis (CRS) versus a control group. Bromelain is derived from pineapple (Ananas comosus) and has various pharmacological effects. 40 patients (20 patients and 20 controls) were enrolled in the study. Bromelain 500 mg tablet twice daily was administered for 30 days. We scored bromelain presence in turbinate and ethmoid mucosas and in the serum of both the groups. Bromelain has an excellent distribution from blood to rhinosinusal mucosa. Its diffusion ability may allow the use of bromelain as an anti-inflammatory agent in paranasal sinus pathologies.
9
European Position Paper on Rhinosinusitis and Nasal Polyps 2020
W.J. Fokkens, Valerie J. Lund, C. Hopkins et al. · Rhinology Journal · 2020 · 5.5K citations · Full text
Medicine, Otolaryngology, Surgery +16
V J Lund, I S Mackay · PubMed · 1993 · 1.5K citations
[European position paper on rhinosinusitis and nasal polyps group].
Wytske J. Fokkens, Valerie J. Lund, Joaquim Mullol · PubMed · 2008 · 529 citations
Medicine, Otolaryngology, Surgery +13